Clinical trial

IBI188 Combination Therapy in Solid Tumors

NCT04861948

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2021-05-25

PhasePHASE1

Study timeline

Study start (actual)2021-05-25Date precision: day

Registry last updated2022-10-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Solid Tumorsunresolved

Lung Adenocarcinomaverified · MONDO: lung adenocarcinoma

Osteosarcomaverified · MONDO: osteosarcoma

Interventions

Cisplatin/CarboplatinDRUG

BevacizumabDRUG · verified · RxNorm: bevacizumab

PemetrexedDRUG · verified · RxNorm: pemetrexed

Sponsors & collaborators

Innovent Biologics (Suzhou) Co. Ltd.lead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04861948 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.